Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
Cantor Fitzgerald
Boehringer Ingelheim
US Department of Justice

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,251,912

« Back to Dashboard

Which drugs does patent 6,251,912 protect, and when does it expire?

Patent 6,251,912 protects GILOTRIF and is included in one NDA. There has been one Paragraph IV challenge on Gilotrif.

Summary for Patent: 6,251,912

Title: Substituted quinazoline derivatives
Abstract:This invention provides compounds of formula 1 having the structure ##STR1## wherein: X, R.sub.1, R.sub.2, R.sub.3, R.sub.4, Z, X, and n are as defined hereinbefore in the specification, which are useful as antineoplastic agents and in the treatment of certain kidney diseases, such as polycystic kidney disease.
Inventor(s): Wissner; Allan (Ardsley, NY), Tsou; Hwei-Ru (New City, NY), Johnson; Bernard D. (Stony Point, NY), Hamann; Philip R. (Garnerville, NY), Zhang; Nan (Suffern, NY)
Assignee: American Cyanamid Company (Madison, NJ)
Application Number:09/124,365
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Boehringer IngelheimGILOTRIFafatinib dimaleateTABLET;ORAL201292-001Jul 12, 2013RXYesNo► Subscribe► SubscribeYYTREATMENT OF CANCER► Subscribe
Boehringer IngelheimGILOTRIFafatinib dimaleateTABLET;ORAL201292-002Jul 12, 2013RXYesNo► Subscribe► SubscribeYYTREATMENT OF CANCER► Subscribe
Boehringer IngelheimGILOTRIFafatinib dimaleateTABLET;ORAL201292-003Jul 12, 2013RXYesYes► Subscribe► SubscribeYYTREATMENT OF CANCER► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Queensland Health
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: